Compounds > levodopa

Page last updated: 2024-08-17

levodopa and cqa 206-291

levodopa has been researched along with cqa 206-291 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hofman, R; Pfeiffer, RF	1
Dupont, E; Fabre, N; Hirt, D; Hoyer, M; Lataste, X; Lücking, C; Poewe, W; Rascol, O; Rinne, U; Teräväinen, H	1
Lang, AE; Lataste, X; Riley, DE; Vachon, L	1

Trials

2 trial(s) available for levodopa and cqa 206-291

Article	Year
CQA 206-291 in Parkinson's disease. Clinical neuropharmacology, 1991, Volume: 14, Issue:2 Topics: Activities of Daily Living; Aged; Dopamine Agents; Double-Blind Method; Drug Interactions; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease	1991
CQA 206-291: a novel dopamine agonist in the treatment of Parkinson's disease. Clinical neuropharmacology, 1990, Volume: 13, Issue:4 Topics: Aged; Antiparkinson Agents; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1990

Other Studies

1 other study(ies) available for levodopa and cqa 206-291

Article	Year
CQA 206-291 in Parkinson's disease: an acute single escalating dosage study. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1990, Volume: 17, Issue:4 Topics: Aged; Antiparkinson Agents; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance	1990